{"id":"W2800810996","doi":"10.1002/hon.2513","title":"Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with <sup>90</sup>Y ibritumomab tiuxetan in a phase II study","year":2018,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Spectrum Pharmaceuticals","keywords":"Medicine; Ibritumomab tiuxetan; Follicular lymphoma; Internal medicine; Rituximab; International Prognostic Index; Oncology; Gastroenterology; Immunotherapy; Vincristine; Lymphoma; Cyclophosphamide; Radioimmunotherapy; Surgery; Immunology; Chemotherapy; Cancer; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003582205,0.0003722092,0.001422963,0.0001927741,0.0001404913,0.00001348015,0.0001585423,0.0002351166,0.0001663459],"category_scores_gemma":[0.00011097,0.0002350377,0.0001141567,0.0003718711,0.0005222007,0.00006331933,0.0002836574,0.0001438623,0.00003695549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002654936,"about_ca_system_score_gemma":0.0001066219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000497376,"about_ca_topic_score_gemma":0.0003247964,"domain_scores_codex":[0.9973522,0.0003391746,0.000744693,0.0007373486,0.0003237447,0.0005028518],"domain_scores_gemma":[0.998401,0.0003979274,0.0003457856,0.0004877951,0.00009812524,0.0002693331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004180615,0.04037429,0.7803363,0.0001291102,0.001059891,0.02587122,0.002038843,0.000005846893,0.00001053624,0.00198115,0.000369999,0.1436422],"study_design_scores_gemma":[0.1062129,0.08513454,0.7966406,0.0003307265,0.001631421,0.0009258951,0.003951531,0.0004660581,0.0006647287,0.0006091103,0.00306307,0.0003693884],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956792,0.0005176018,0.00004732713,0.0003545228,0.00006572044,0.001952808,0.00002350131,0.00006888645,0.001290458],"genre_scores_gemma":[0.9965134,0.0007257891,0.001900539,0.0001904126,0.00006140778,0.0005239354,0.00002198773,0.00002481744,0.00003766524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1432729,"threshold_uncertainty_score":0.958456,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01419383430954533,"score_gpt":0.2984657552718471,"score_spread":0.2842719209623017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}